reported in literature for chronic kidney disease stages, and these subgroups were not analyzed in such detail as the disease-based subgroups. -associated lipocalin (NGAL), osteopontin, trefoil factor 3 (TFF-3), calbindin (calbindin-1, CALB1, calbindin-D28k), glutathione -S-transferase-π (GST-π, GST-pi), interleukin 18 (IL-18), kidney injury molecule 1 (KIM-1), and monocyte chemoattractant protein 1 (MCP-1), are predominantly found in urine and serve as good indicators of numerous kidney dysfunctions. Moreover, some of them are exclusively related to certain parts of the nephron, providing information on the site of the injury, and their blood levels may serve as a valuable indicator or predictor of certain kidney dysfunction. Together with the indicators of kidney function, creatinine (Cr) and cystatin C, the above biomarkers yield useful information on kidney function. So far, not many researchers have focused on the serum levels of known kidney-specific and nonspecific markers of renal function or injury. Therefore, the aim of our study was to evaluate the levels of these markers in the serum of patients with diagnosed primary or secondary GN, with or without the presence of NS or AH. Our results may fill in the gap in the current literature data on serum levels of these factors, as well as help determine the potential future directions of research.
PATIENTS AND METHODS Study design
Most of the factors described and evaluated in this study were predominantly measured in urine and normalized using urine Cr. Considering that changes in the serum levels of the analyzed factors can result from numerous other physiological and pathophysiological conditions not considered in this publication, such as cancer or inflammatory diseases (including autoimmune ones), the major study exclusion criterion was the presence of any diseases or dysfunctions that could affect the results. The inclusion criterion was the presence of diseases underlying the development and progression of GN classified as either nephrotic GN (GN+NS) or nonnephrotic GN (GN). As hypertension is strongly related to renal function, patients with GN with associated AH constituted the next subgroup: GN and AH without NS (GN+AH). AH was not observed in patients from the GN+NS subgroup. The design of our study allowed us to include a small group of patients with congenital defects (CD) of the kidneys as a group of kidney diseases of a completely different etiology. All patients with CDs had AH (the CD+AH subgroup).
All patients were also independently divided into subgroups based on estimated glomerular filtration rate (eGFR) calculated using the Modification of Diet in Renal Disease formula: G1 included patients with eGFR exceeding 90 ml/min/1.73 m This classification was introduced mainly to compare the obtained results with reference ranges all the above equations, as well as a positive correlation between KIM-1, NGAL, and IL-18 and cystatin C levels. Weak to moderate correlations with eGFR were also observed for β 2 M, TFF-3, and calbindin. Interestingly, in the GN+NS subgroup, the above trend for calbindin was reversed: it showed a strong positive correlation with eGFR evaluated using the MDRD equation, as well as a similar trend, although without statistical significance, with the other 3 eGFR determinants. There were no correlations between serum levels of renalase, osteopontin, MCP-1, and GST-π and eGFR evaluated using the 4 equations. Only in the CD+AH subgroup, GST-π showed a significant negative correlation with eGFR. Detailed correlation coefficients between studied factors and Cr, cystatin C, and eGFR are presented in supplementary material online (Supplementary material online, Table S1 ).
Some of the analyzed biomarkers correlated positively with one another. MCP-1 was the only marker that showed negative correlations: with renalase in the GN+NS group (r = -0.81; P <0.05) and with KIM-1 in the CD+AH group (r = -0.86, P <0.05). As mentioned above, NGAL, KIM-1, IL-18, TFF-3, and β 2 M showed a strong to moderate correlation with eGFR; these markers generally showed more correlations than the other ones. Coefficients are presented in Supplementary material online (Table S2) , and the more important ones are explained in more detail in the Discussion section.
Characteristics of the subgroups divided according to estimated glomerular filtration rate Detailed characteristics of biochemical parameters as well as significant differences between the subgroups divided according to eGFR are shown in TABLE 3. Significant differences between the markers of renal injury were found for MCP-1, KIM-1, IL-18, TFF-3, NGAL, and β 2 M. This was not surprising considering their strong to moderate correlations (except for MCP-1) with eGFR, as shown for the whole study group and disease based subgroups. The levels of TFF-3, NGAL, β 2 M, and cystatin C (as not included in the MDRD eGFR subgroups) gradually increased with the stages of the disease.
The most interesting correlations between biomarkers that were not correlated with eGFR were observed in the G1 and G2 subgroups. In the G1 subgroup, we found a negative correlation between renalase and MCP-1 (r = -0.53, P <0.05) and a positive one between GST-π and calbindin (r = 0.48, P <0.05); in the G2 subgroup, we found a correlation between renalase and osteopontin (r = 0.49, P <0.05) and between MCP-1 and osteopontin (r = 0.54, P <0.05). Detailed correlations between all markers in the eGFR subgroups are presented in Supplementary material online, Table S3 .
Multiple logistic regression The multiple logistic regression showed that when GN was the dependent variable, IL-18 was a significant biomarker in The study was approved by a local ethics committee.
Statistical analysis Data were analyzed using the STASTISTICA 12.5 software (StatSoft, Tulsa, Oklahoma, United States). The descriptive statistics involved calculation of the mean value, standard deviation, and minimum and maximum values of quantitative variables. The assumption of normality was verified using the Shapiro-Wilk test. The analyzed parameters were compared within the distinguished subgroups using the t test. In the absence of the homogeneity of variance, the Welch test (modification of the t test) was applied. In the absence of normality, the Mann-Whitney test was used. When the parameters were compared within more than 2 groups, the Kruskal-Wallis analysis of variance and post hoc tests were applied. Correlations between selected parameters were analyzed using the Pearson correlation coefficient.
In order to further explore the predictive properties of the tested biomarkers, we constructed 4 logistic multiple regression models. The dependent (explained) variables were GN and its derivatives (GN + NS and GN + AH), as well as CD + AH, whereas the 12 analyzed serum biomarkers were considered as independent variables (explanatory variables, predictors). The goodness of fit of the model was assessed using the Hosmer-Lemeshow test. The receiver-operating characteristic curve (ROC) was constructed and the area under the curve (AUC) was calculated. The level of statistical significance was set at an α value of 0.05. RESULTS Characteristics of the study group and the subgroups divided according to disease The study involved patients at a mean age of 46.3 ±16.2 years, including 28 women and 36 men. TABLE 1 presents the levels of the analyzed markers, as reported in the available literature for healthy individuals and those with kidney and heart diseases. TABLE 2 presents the characteristics of the analyzed biomarkers, together with any significant differences between the subgroups of patients divided according to disease.
Correlations in the subgroups divided according to disease The analysis of correlations between the analyzed biomarkers and indicators of kidney function (Cr, cystatin C, and eGFR) in the whole study group (n = 64) showed a moderate to strong negative correlation between KIM-1, NGAL, and IL-18 and with eGFR calculated using 
DISCUSSION
To the best of our knowledge, we were the first to analyze the serum levels of kidney toxicity markers using the Bio-Plex method (Kidney Toxicity Panels 1 and 2). Most of similar studies were performed using immunoenzymatic tests; therefore, we are aware that the use of a different method may have provided discrepant results. We found numerous similarities between our results and those obtained by other investigators, mainly with regards to MCP-1. IL-18 and TFF-3 showed about 2-to 4-fold higher levels than those reported in other studies for different stages of chronic kidney disease, 3,4 but similarly to those data, the IL-18 and TFF-3 levels increased together with a decrease in eGFR. IL-18 levels were similar to those observed for patients with IgA nephropathy (466.6 pg/ml vs 360.26 pg/ml, respectively).
5 NGAL levels were also similar, although
When the dependent variables were GN+NS and GN+AH, none of the parameters studied were significant in explaining the dependent variable. When the dependent variable was CD+AH, significant predictors in the logistic regression model were osteopontin (OR, 0.987; 95% CI, 0.976-0.998; P = 0.024) and KIM-1 (OR, 1.039; 95% CI, 1.011-1.068; P = 0.0002). The Hosmer-Lemeshow test allowed us to accept the hypothesis of the goodness of fit of the model (P = 0.84). The AUC was 0.951 (FIGURE 2). The ROC curve was also calculated seperately for KIM-1 and osteopontin, and the AUC for those biomarkers was 0.875 and 0.77, respectively (data not shown).
The detailed results of the different eGFR subgroups are shown in TABLE 3. Since diversity of this group is based on MDRD eGFR, only the most important differences and correlations are presented in the Discussion section. levels seems to be more complex. The serum levels of MCP-1, a molecule considered to be a product of a wide range of cells and tissues (especially monocytes and macrophages), may indicate numerous inflammatory processes because MCP-1 acts mainly as a proinflammatory chemokine. 22 Macrophages are the principal kidney infiltrating population of leukocytes in type 2 diabetes mellitus, and the MCP-1 expression in glomerular and interstitial compartments of the kidney correlates with albuminuria and outcome of kidney function, due to high infiltration and kidney damage caused by macrophages. 23,24 Also in a study by Morii et al, 25 the urinary levels of MCP-1 correlated positively and significantly with urinary albumin levels, which was caused by an increased leakage of plasma protein from the glomerular capillary to tubular fluid. This also explains why significant outcome was limited only to the NS subgroup in our study. A negative correlation between MCP-1 and renalase levels is not completely clear due to still unclear properties of renalase; most theories suggest that renalase is an enzyme with high affinity to biogenic amines. However, recent findings have shown that it might be also an anti-inflammatory cytokine that increases cell survival, and a single nucleotide polymorphism in the renalase gene is a high-risk factor for developing diabetes mellitus. 26 Also, in the animal model of acute kidney injury, administration of renalase correlated with renal protection and lower macrophage infiltration of the kidney, 26 which taken together with our results can be the basis for a hypothesis that renalase might inhibit the activity of MCP-1 in patients with NS. Therefore, the correlation between MCP-1 and renalase levels should be further studied in patients with other primary and secondary kidney diseases, especially diabetic nephropathy.
Similarly to MCP-1, renalase, and osteopontin, GST-π levels in our study did not correlate with kidney function, as assessed using the Cr, cystatin C, and eGFR equations. The only exception was the CA+AH subgroup, in which it was significantly correlated with KIM-1 and NGAL levels. The discrepancy in the results between the subgroups with and without GN might have been caused by the fact that GN is accompanied by chronic oxidative stress, which may lead to further oxidative injury, and that high levels of reactive oxygen species upregulate the expression of GST-π. This might have hidden potential correlations. 10, 27, 28 The remaining biomarkers, β 2 M, NGAL, TFF-3, calbindin, IL-18, and KIM-1, in most cases correlated linearly and negatively with kidney function and injury measured by all 4 eGFR equations. A decrease in eGFR may generally be associated with increased serum levels of the above factors by stimulating their production and release in response to damage, or by modification or even inhibition of their catabolism, or by increased resorption in different parts of the nephron. Considering that the majority of those factors are slightly higher in our study than in other studies on patients with kidney diseases. [6] [7] [8] As for calbindin, no studies have reported its levels in renal patients so far. In healthy individuals, calbindin levels were found to be lower than 20 pg/ml and were undetectable using a commercially available enzyme-linked immunosorbent assay, 9 while our study showed that the mean value in patients with kidney diseases was 28.8 ng/ ml. Similarly, serum levels had not been studied before in renal patients. The mean GST-π levels were reported to be 9.2 ng/ml in healthy people, 10 while in our study, they reached 49.9 ng/ ml. The mean levels of KIM-1 (65.9 pg/ml) and β 2 M (1.124 µg/ml) in our study were comparable to those described for healthy people in other studies, and were much lower than those in patients with kidney diseases. [11] [12] [13] [14] [15] As for osteopontin, its mean level in our study was 614.2 ng/ml, while in the literature, its levels in patients with chronic kidney disease were reported to be, depending on the study, in the range between 1.71 and 53 ng/ml. [16] [17] [18] [19] [20] Of note, cystatin C concentrations were in the range between 0.4 and 2.7 mg/l in our study, which is consistent with existing literature data. Therefore, we were able to calculate eGFR using formulas containing cystatin C concentrations.
The serum levels of renalase, MCP-1, GST-π, and osteopontin seem to be eGFR-independent factors involved in kidney damage. Correlations between renalase and osteopontin in the whole study group and in the GN+AH subgroup suggest that there might be a common mechanism underlying their release, mechanism of action, or degradation. Together with osteoprotegerin, matrix γ-carboxyglutamic acid protein, and fetuin A, osteopontin is involved in the inhibition of atherosclerotic calcification. 16 In blood, osteopontin plays a role of a proinflammatory protein and potentially chemotactic molecule for neutrophils and macrophages, and similarly to KIM-1, plays an important role in immune response. 12 In our study, increase in osteopontin levels was associated with a small, but significant reduction in the odds of kidney disease (while KIM-1 had an opposite effect) in the CD+AH subgroup, which probably resulted from an inhibitory effect of this molecule on vascular calcification and nephrocalcinosis, or from much more complicated relations associated with the mechanism regulating the process of bone destruction in kidney disease. It cannot be also excluded that this protective role is related to antiapoptic and immunostimulatory properties of osteopontin. 21 MCP-1 levels were similar in all analyzed subgroups, except for the CD+AH subgroup, in which 2-fold higher concentrations were observed. Two strong negative correlations, namely, with renalase in the GN+NA subgroup and with KIM-1 in the CA+AH subgroup, are particularly interesting. While a negative correlation with KIM-1 probably results from the elevated levels of this molecule, a negative correlation with renalase
Conclusions Taken together, it should be noted that renalase and MCP-1 in NS might have an opposite effect and regulate each others' levels. Further studies should investigate the relations between renalase, MCP-1, and osteopontin, as factors unrelated to eGFR in patients with GN. As renalase and MCP-1 were frequently reported to be associated with diabetes mellitus, a group of diabetes patients should be also included. NS may contribute to loss of calbindin from serum, but it cannot be excluded that accumulation of calbindin may stimulate the gradual loss of kidney function. NGAL, KIM-1, TFF-3, IL-18, β 2 M, and calbindin are good indicators of kidney function loss evaluated using the 4 eGFR equations in patients with GN, which confirms the findings from single previous studies.
Our study describes numeorus factors measured at the same time and in the same conditions, many of which have never been described in detail or even described at all in the serum of patients with kidney disease, including glomerulonephtiris and congenital kidney defects. Some of the observations are obviously not accidental and can be the basis for further research.
Limitations Due to the pioneering design of the study, which required experimental determination of the optimal dilution of serum samples to obtain reliable results, we had to perform it in duplicates. Therefore, in order to perform the assays in the largest possible group of patients, we decided not to enroll the control group. To refer to normal, physiological levels of the analyzed biomarkers, we used literature data. Nevertheless, we believe that the results are interesting enough to be published.
We are aware that due to a small size of our subgroups, some of the differences and correlations may be accidental and some of the results might not have reached statistical significance. Furthermore, not all our results may be compared to existing literature data because of different methods used.
Contribution statement NMS designed the study and performed the immunoenzymatic assays. MW drafted the clinical part of article, and analysed the data. AJ, ES, and ZM collected material and data, and performed biochemical assays. BD supervised the study, as well as edited and corrected the draft of the article. bound to or produced by immune cells, the increase of their serum levels is caused by inflammation, and increased levels of leukocytes and antibodies during immune response contribute to disease progression.
IL-18 is a cytokine with a wide variety of functions. Its levels correlate with the severity of numerous diseases, including circulatory disorders, kidney injury, autoimmune diseases. 5,29,30 IL-18 is not only a marker of tissue damage but is also actively involved in the damage process of numerous other organs. 30 It has been shown that an increase in serum IL-18 levels may result in worse renal outcome. In addition, it may be a marker of kidney disease progression in patients diagnosed with IgA nephropathy or ischemic acute kidney injury. 31 This results from the proinflammatory properties of IL-18, the activity of caspase 1 (which processes the inactive form of IL-18), the presence of IL-18-binding protein, and the regulatory role of IL-18 in the production of interferon γ. 30 In some situations, IL-18 may also play a protective role; it probably prevents the development of metabolic syndrome or macular degeneration. 30 Our study showed that in contrast to the majority of the reports published, IL-18 lowers the odd of kidney disease in patients with GN.
TFF-3 is a less well-analyzed marker of kidney function. Nonetheless, at least one large study showed that its concentration increases with the progression of kidney disease. 26 Our study, although performed on a much smaller group of patients and therefore analyzed using nonparametric tests, showed the same tendency but with about 4-fold higher levels than those reported in literature for each stage. The most recent data show that this molecule was underestimated in epithelial restitution and regeneration in injured kidneys, and that TFF-3 release is stimulated by nutrient starvation and hypoxia. 4 As the TFF-3 level correlated with eGFR in most subgroups, its correlation with the most common and possibly the most accurate markers, NGAL, KIM-1, IL-18, and β 2 M, is not a surprising finding.
The negative correlation between calbindin and eGFR in patients with GN and NS, as observed in our study, suggests that NS is not just a consequence of kidney damage but also a factor that should guide the decision on the type of therapy for NS. Calbindin is a crucial protein involved in bone remodeling, with antiapoptotic properties shown for neuronal cells as a result of its calciumbuffering and caspase-3 inhibiting properties.
32
Of the biomarkers analyzed in this study, calbindin is the only indicator of damage to kidney collecting ducts; it is also related to the condition of distal tubules. 33 Therefore, it is considered to be a good biomarker of distal nephron segment injuries, which cause its decrease, and unlike the other biomarkers, renal damage with proteinuria is diagnosed on the basis of increased calbindin expressions, rather than decreased one.
